Search & Analyze
Popular Searches
Sun Pharmaceutical Industries Ltd.
Healthcare₹1,941.000.64%
24 Jul, 4:01 PM
CMP₹1,941.00
Mkt Cap₹4.69L Cr
P/E40.84
P/B5.61
ROE14.85%
52W High₹1,966.75
52W Low₹1,547.25
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
40.84
P/B Ratio
5.61
EV/EBITDA
23.41
Price/Sales
8.02
Dividend Yield (%)
0.82
EPS (TTM ₹)
47.84
Book Value (₹)
348.31
ROE (%)
14.85
ROCE (%)
19.11
ROA (%)
12.02
EBITDA Margin (%)
28.21
Net Profit Margin (%)
19.78
Debt/Equity
0.05
Current Ratio
2.82
Interest Coverage
45.61
Asset Turnover
0.61
Working Capital/Sales
1.42
Core EBITDA Growth (%)
14.31
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 386544.9 | 438856.8 | 484968.5 | 525784.4 | 584620.4 |
| Net Sales | 386544.9 | 438856.8 | 484968.5 | 525784.4 | 584620.4 |
| Total Income | 400919.1 | 445794.3 | 501250.9 | 547290.1 | 616739.4 |
| Total Expenditure | 287726.8 | 322981.2 | 357477.7 | 374922.8 | 419708.2 |
| Operating Profit | 113192.3 | 122813.1 | 143773.2 | 172367.3 | 197031.2 |
| Depreciation | 21437.4 | 25294.3 | 25566.4 | 25753.9 | 29378.5 |
| Exceptional Items | -45668.2 | -1714.5 | -4943.2 | -6778.5 | -13074.8 |
| Profit Before Tax | 44813.2 | 94084.3 | 110878.9 | 137521.3 | 151188.8 |
| Tax | 10755 | 8475.9 | 14394.5 | 27720.3 | 35543.6 |
| Profit After Tax (PAT) | 34058.2 | 85608.4 | 96484.4 | 109801 | 115645.2 |
| EPS (₹) | 13.6 | 35.3 | 39.9 | 45.6 | 47.8 |
| Dividend Payout % | 1000 | 1150 | 1350 | 1600 | 1600 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 2399.3 | 2399.3 | 2399.3 | 2399.3 | 2399.3 |
| Reserves | 477712.9 | 557554.5 | 634268.2 | 719780.9 | 833301.6 |
| Shareholders Funds | 480112.2 | 559953.8 | 636667.5 | 722180.2 | 835700.9 |
| Total Debt | 9306.9 | 61978.8 | 28456.9 | 18696.3 | 40816.1 |
| Total Liabilities | 669581.9 | 772246.7 | 813960 | 876930.3 | 1047387.6 |
| Total Assets | 669581.9 | 772246.7 | 813960 | 876930.3 | 1047387.6 |
| Book Value / Share | 200.1051 | 233.3822 | 265.3555 | 300.9962 | 348.3103 |
| Assets | 669581.9 | 772246.7 | 813960 | 876930.3 | 1047387.6 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 89845.4 | 49593.3 | 121349.8 | 140720.9 | 124191.8 |
| Investing Activities | -57247.4 | -79436.8 | -6902 | -53061.6 | -113440.5 |
| Financing Activities | -51934.6 | 23760.7 | -67101.6 | -79058.2 | -25125.5 |
| Net Cash Flow | -19336.6 | -6082.8 | 47346.2 | 8601.1 | -14374.2 |
SUNPHARMA
₹1,941.00
-0.64%